United States · FDA National Drug Code directory
EGATEN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0078-0937_09bbe9c5-f4a7-4140-8a74-809125cd7861
- Product NDC
- 0078-0937
- Form
- TABLET
- Composition / generic term
- triclabendazole
- Labeler
- Novartis Pharmaceuticals Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190213
- Source listing expiry
- 20271231
Source-listed ingredients
- TRICLABENDAZOLE — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 TABLET in 1 BLISTER PACK (0078-0937-91) · 0078-0937-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →